KATHYA JIMENEZ: Open Payments
NPI 1528754868 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 44 payments from 25 companies in 2025. Trend: 2023 $1,078 · 2024 $1,812 · 2025 $1,379
Food & beverage: $1,280Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $269 |
| Daiichi Sankyo Inc. | 3 | $139 |
| EMD Serono, Inc. | 2 | $137 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Incyte Corporation | 1 | $110 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
Products named: Enhertu, LIBTAYO, Monjuvi, Fabhalta, SCEMBLIX, KISQALI, EPKINLY, ORGOVYX.
Industry payments across AZ — which companies pay providers there.
